Catalytic Antioxidant treatment of sod2 nullizygous mice

• Evaluate efficacy in preventing early neonatal death

• Pharmacokinetic properties - effects on tissue pathologies

• Uncovery of novel phenotypes associated with endogenous oxidative stress

  Includes genomic and proteomic targets which are responsive to the antioxidant being employed
  

Previous slide

Next slide

Back to first slide

View graphic version